Comparing more than five thousand cancers of the types smoking causes showed exactly how tobacco does its damage: in the tissues smoke touches directly it leaves a chemical fingerprint in the DNA, and elsewhere it acts more indirectly.
Somatic mutations and DNA methylation were analysed in 5,243 cancers of types for which tobacco smoking confers an elevated risk. Smoking is associated with increased mutation burdens of multiple distinct mutational signatures, contributing to different extents in different cancers. One of these, found mainly in cancers derived from tissues directly exposed to tobacco smoke, is attributable to misreplication of DNA damage caused by tobacco carcinogens. Others likely reflect indirect activation of DNA editing by APOBEC cytidine deaminases and of an endogenous clock-like mutational process. Smoking is associated with only limited differences in methylation. The results support the proposition that smoking increases cancer risk by increasing the somatic mutation load, although direct evidence is lacking for some smoking-related cancer types.
It supplies the chemistry behind the allele spectrum of lung cancer: the G to T transversion that the tobacco signature generates is why KRAS G12C dominates in lung and G12D dominates in bowel and pancreatic cancer.
Shares Mutagenesis & mutational signatures, Mutational signature, Tumour mutational burden (TMB), Whole-exome & whole-genome sequencing.
Shares Mutagenesis & mutational signatures, Mutational signature, Whole-exome & whole-genome sequencing, TP53.
Shares Mutagenesis & mutational signatures, Mutational signature, Tumour mutational burden (TMB), Whole-exome & whole-genome sequencing.
Shares Mutagenesis & mutational signatures, Mutational signature, Tumour mutational burden (TMB), Whole-exome & whole-genome sequencing.
Shares Science, Theories of cancer: how the ideas connect, Mutational signature, Tumour mutational burden (TMB).
Shares KRAS G12D (and other non-G12C KRAS mutations), KRAS mutation subtypes (G12C, G12D, G12V), TP53, KRAS.
Shares KRAS G12D (and other non-G12C KRAS mutations), KRAS mutation subtypes (G12C, G12D, G12V), KRAS.
Shares Mutational signature, Tumour mutational burden (TMB), Whole-exome & whole-genome sequencing.